» Articles » PMID: 17765980

Increased Calpain Correlates with Th1 Cytokine Profile in PBMCs from MS Patients

Overview
Journal J Neuroimmunol
Specialty Neurology
Date 2007 Sep 4
PMID 17765980
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis (MS) is a devastating autoimmune demyelinating disease of the central nervous system (CNS). This study investigated whether expression and activity of the calcium-activated protease calpain correlated with Th1/Th2 dysregulation in MS patients during states of relapse and remission. Calpain expression and activity were significantly increased in peripheral blood mononuclear cells (PBMCs) from MS patients, compared to controls, with the highest expression and activity noted during relapse. Th1 cytokines were highest and Th2 cytokines were lowest in MS patients during relapse. Treatment with calpain inhibitor, calpeptin, decreased Th1 cytokines in PBMCs from MS patients. Calpain inhibitor also reduced degradation of myelin basic protein (MBP) by inhibiting the calpain secreted from MBP-specific T cells. Taken together, these results suggested calpain involvement in Th1/Th2 dysregulation in MS patients.

Citing Articles

Genetic susceptibility and causal pathway analysis of eye disorders coexisting in multiple sclerosis.

Qiu X, Huang M, Ping S Front Immunol. 2024; 15:1337528.

PMID: 38375484 PMC: 10875133. DOI: 10.3389/fimmu.2024.1337528.


Association of multiple sclerosis with chronic fatigue syndrome, restless legs syndrome, and various sleep disorders, along with the recent updates.

Prajjwal P, Kalluru P, Marsool M, Inban P, Gadam S, Al-Ezzi S Ann Med Surg (Lond). 2023; 85(6):2821-2832.

PMID: 37363482 PMC: 10289738. DOI: 10.1097/MS9.0000000000000929.


Intracellular versus extracellular inhibition of calpain I causes differential effects on pain in a rat model of joint inflammation.

McDougall J, McConnell M, Reid A Mol Pain. 2021; 17:17448069211016141.

PMID: 34006144 PMC: 8138287. DOI: 10.1177/17448069211016141.


Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.

Atabati H, Yazdanpanah E, Mortazavi H, Gharibian Bajestani S, Raoofi A, Esmaeili S Adv Exp Med Biol. 2021; 1286:87-105.

PMID: 33725347 DOI: 10.1007/978-3-030-55035-6_6.


Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression.

Sundaram G, Lim C, Brew B, Guillemin G J Neuroinflammation. 2020; 17(1):176.

PMID: 32505212 PMC: 7276083. DOI: 10.1186/s12974-020-01844-y.


References
1.
Schaecher K, Goust J, Banik N . The effects of calpain inhibition on IkB alpha degradation after activation of PBMCs: identification of the calpain cleavage sites. Neurochem Res. 2004; 29(7):1443-51. DOI: 10.1023/b:nere.0000026410.56000.dd. View

2.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

3.
Giuliani F, Goodyer C, Antel J, Yong V . Vulnerability of human neurons to T cell-mediated cytotoxicity. J Immunol. 2003; 171(1):368-79. DOI: 10.4049/jimmunol.171.1.368. View

4.
Glading A, Lauffenburger D, Wells A . Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol. 2002; 12(1):46-54. DOI: 10.1016/s0962-8924(01)02179-1. View

5.
Ray S, Banik N . Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr Drug Targets CNS Neurol Disord. 2003; 2(3):173-89. DOI: 10.2174/1568007033482887. View